Back to search
FDAFDA · Food and drugs·Recall number D-0258-2021

Meclizine HCl Tablets, USP, 12.5 mg, 100 Tablets bottles, Rx Only, Mfd. for: Wilshire Pharmaceuticals, Inc., Atlanta, GA 30328, Product of India, NDC 52536-129-01

Published February 24, 2021 · Recall initiated: February 4, 2021

Summary

FDA records drug Class II recall D-0258-2021, published February 24, 2021 and initiated February 4, 2021. Recalling firm: Wilshire Pharmaceuticals Inc; Status: Terminated; Reported quantity: 2112 bottles; Lot: Lot #: 18030318, Exp 03/2021. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Wilshire Pharmaceuticals Inc
Distributor
FL, TX
Lot
Lot #: 18030318, Exp 03/2021
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Meclizine HCl Tablets, USP, 12.5 mg, 100 Tablets bottles, Rx Only, Mfd. for: Wilshire Pharmaceuticals, Inc., Atlanta, GA 30328, Product of India, NDC 52536-129-01 recalled?

Yes. FDA published recall D-0258-2021 on February 24, 2021. Reported hazard: Failed Dissolution Specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter